How to target adverse drug events using cost-benefit analysis

被引：0
|
作者：
Basskin, L
机构：
来源：
FORMULARY | 1996年 / 31卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：507 / &
页数：5
相关论文
共 50 条
  • [21] Cost-benefit and cost-effectiveness analysis of drug abuse treatment services
    Cartwright, WS
    EVALUATION REVIEW, 1998, 22 (05) : 609 - 636
  • [22] In Defence of Cost-Benefit Analysis
    Ergas, Henry
    AGENDA-A JOURNAL OF POLICY ANALYSIS AND REFORM, 2009, 16 (03) : 31 - 40
  • [23] Cost-benefit analysis: examples
    Linn, Mott
    BOTTOM LINE, 2011, 24 (01): : 68 - 72
  • [24] EQUITY IN COST-BENEFIT ANALYSIS
    PEARCE, DW
    WISE, J
    JOURNAL OF TRANSPORT ECONOMICS AND POLICY, 1972, 6 (03) : 324 - 325
  • [25] Liraglutide: A Cost-Benefit Analysis
    Schoeffski, O.
    Mentrup, S.
    Lund, N.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2010, 19 (03): : 177 - 184
  • [26] Cognition and cost-benefit analysis
    Sunstein, CR
    JOURNAL OF LEGAL STUDIES, 2000, 29 (02): : 1059 - 1103
  • [27] Towards Improved Guidelines for Cost-Benefit Analysis of Sport and Cultural Events
    Massiani, Jerome
    ECONOMIC PAPERS, 2020, 39 (03): : 270 - 289
  • [28] Rethinking cost-benefit analysis
    Adler, MD
    Posner, EA
    YALE LAW JOURNAL, 1999, 109 (02): : 165 - +
  • [29] The discipline of cost-benefit analysis
    Sen, A
    JOURNAL OF LEGAL STUDIES, 2000, 29 (02): : 931 - 952
  • [30] Cost-benefit analysis of the RFA
    Dovich, Norman J.
    Soper, Steven A.
    SCIENCE, 2006, 314 (5806) : 1682 - 1682
12345